Prepared for the CoreAge Rx network Read the disclosure ↗
Reading library /

Guide · Checked September 27, 2026

Changing TRT services: transfer the clinical story, not only the latest result

A receiving clinician needs to understand why treatment began, what was supplied and what happened during follow-up. Account registration alone does not transfer responsibility.

Based on public documents · No clinician sign-off or firsthand treatment testing

A change of testosterone service may begin with a practical concern: price, communication, location or a clinician leaving a practice. The administrative move can be quick, while the medical handoff takes more explanation. A new account and an uploaded laboratory report do not necessarily tell the receiving clinician why treatment began or what has happened since.

This guide describes the records and responsibilities to clarify during that transition. It does not advise a gap, a bridge prescription, a dose change or a way to avoid reassessment. The useful aim is continuity of information and an explicit handoff, with any treatment instructions coming from the professionals involved.

What this article covers

Start with the original assessment, not just the current hormone number

Request the clinical account of the symptoms and findings that led to the initial treatment decision, including the relevant laboratory reports and explanation of the diagnosis. The Endocrine Society’s July 2026 statement emphasizes symptoms, consistent accurate measurements and assessment of contributors. A receiving clinician may need that history to understand what was established before treatment.

Reports obtained before and during therapy answer different questions and should remain identifiable as such. Do not try to recreate missing baseline information by changing treatment yourself. Explain what records exist and let the receiving clinician decide how to assess the situation. Missing documentation is a reason for clarification, not an invitation to invent an earlier diagnosis or result.

Describe the original treatment goal in ordinary language as well as preserving records. That helps the next clinician ask whether the same concern still matters.

Collect the prescription history as well as the medicine list

Include the actual medicine labels and information about the prescriber and dispensing pharmacy. Identify previous changes and the documented reasons when available. A list that says testosterone alone may omit the formulation, concentration or route needed to understand the previous care. Other prescription and nonprescription products also belong in the clinical history.

The pharmacy-record guide explains those distinctions. A label from the specific Depo-Testosterone product cannot establish the contents of an unidentified compounded preparation. The receiving clinician and pharmacist should resolve the actual product identity, especially when the new service’s catalog uses similar names but may involve different formulations or dispensing arrangements.

Transfer follow-up findings, including unresolved concerns

Bring the reports and clinical notes used to review benefit, adverse effects and safety during treatment. The Endocrine guideline calls for evaluation after initiation; knowing only that tests were performed does not show what the treating clinician concluded. Include ongoing symptoms and questions still awaiting an answer, not just results that appear reassuring.

Blood-pressure information and relevant blood-count or prostate-related assessment may be part of that history, depending on the clinical plan. Ask who currently holds each record and which team will respond to a result that arrives during the transition. The laboratory handoff guide distinguishes report delivery from interpretation. Avoid assuming that both practices are reviewing the same information.

Request copies through the organization that holds them

HHS explains that patients generally have a right, with exceptions, to inspect and receive copies of medical and billing records held by providers and plans covered by the Privacy Rule. That scope matters: the rule should not be described as an identical promise from every wellness app or retail website. Ask the relevant practice or laboratory about its records-request process.

A portal may provide some documents without containing the full assessment or all outside reports. Specify what is needed and ask how it can be sent in a usable form. HHS also distinguishes access from automatic provider-to-provider sharing. Do not assume a new clinic can retrieve everything merely because both organizations use online systems or the same account email address.

Check that the receiving team has the material and the task

Confirm where records should be sent, whether they arrived and who will review them. An upload confirmation proves a file was submitted, not that a clinical decision has been made. If a report is incomplete or difficult to read, ask the sender for a complete copy rather than manually reconstruct values or omit the reference information.

MedlinePlus explains that results need clinical context and may involve different methods and reference ranges. Keep the original reports available. Ask the receiving clinician what additional assessment, if any, is needed and how current concerns will be addressed. Accepting outside records does not necessarily mean accepting every earlier conclusion or agreeing to continue an existing prescription unchanged.

Clarify access, payment and supply questions before assuming continuity

Ask the existing and receiving teams how responsibility will be handled while the assessment is in progress. Who should receive a medication concern? Which appointments are available? Which pharmacy can answer questions about an existing order? These questions are particularly useful when subscription access, prescribing care and dispensing are handled by separate organizations.

Our price guide addresses financial terms, while the FTC’s guidance supports keeping records of cancellation and subsequent charges. A payment cancellation does not provide medical instructions, and a new payment does not guarantee a prescription or a particular supply date. Raise any anticipated access problem with the clinicians and pharmacist rather than improvising a treatment interruption or replacement.

Make the handoff a documented conversation

Before considering the transfer complete, seek a clear explanation of which clinician is now responsible for treatment decisions, who reviews future tests and how questions reach that team. Include changed fertility goals, new diagnoses or other care that the original practice may not know about. The goal is a shared understanding of current care, not merely an archive of old files.

Our CoreAge service review and comparison examine public arrangements without guaranteeing acceptance of a transferring patient. This guide was prepared for the CoreAge Rx publishing network; the affiliation is relevant to readers evaluating its perspective. It neither endorses treatment nor establishes that a receiving practice will accept a patient. A useful transfer preserves the clinical reasoning and unresolved issues, while leaving the receiving professional responsible for explaining the actual next plan.

Source documents

Read each document beside the claim it supports. A provider’s offer, a clinical guideline and an exact medicine label are different kinds of evidence.

  1. Endocrine Society: Statement on Testosterone Replacement Therapy, July 2026Current professional society statement · Accessed 2026-09-27
  2. Pfizer: Depo-Testosterone prescribing information, revised September 2025Exact product labeling · Accessed 2026-09-27
  3. Endocrine Society: Testosterone Therapy in Men With Hypogonadism, 2018 guidelineClinical practice guideline · Accessed 2026-09-27
  4. HHS: Your Medical Records, reviewed May 30, 2025Federal medical-record access guidance · Accessed 2026-09-27
  5. MedlinePlus: How to understand your lab resultsNIH patient information · Accessed 2026-09-27
  6. FTC: Free trials, auto-renewals and negative-option subscriptionsFederal consumer billing guidance · Accessed 2026-09-27